(Q42462204)

1 November 2017

title

A reappraisal of the significance of largest basal diameter of posterior uveal melanoma (English)

1 reference

1 November 2017

2

1 reference

1 November 2017

B Damato

1

1 reference

1 November 2017

publication date

1 December 2009

1 reference

1 November 2017

1 reference

1 November 2017

volume

23

1 reference

1 November 2017

issue

12

1 reference

1 November 2017

page(s)

2152-60; quiz 2161-2

1 reference

Treatment of primary intraocular melanoma

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

Conservation of eyes with choroidal melanoma by a multimodality approach to treatment: an audit of 1632 patients

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

Tumor, node, metastasis classification of malignant ciliary body and choroidal melanoma evaluation of the 6th edition and future directions.

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

Very long-term prognosis of patients with malignant uveal melanoma

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

When is fever malaria?

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

Cytogenetics of uveal melanoma: a 7-year clinical experience

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28.

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

Plaque radiotherapy for juxtapapillary choroidal melanoma. Visual acuity and survival outcome

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

Prognostic factors in choroidal and ciliary body melanomas

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

Prognosis in uveal melanoma with extrascleral extension

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

Transretinal choroidal tumor biopsy with a 25-gauge vitrector.

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

Multiplex ligation-dependent probe amplification of uveal melanoma: correlation with metastatic death

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

Chromosome 3 analysis of uveal melanoma using fine-needle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases: the Deborah Iverson, MD, Lectureship

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24.

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

Legacy of the collaborative ocular melanoma study

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

Adjuvant intra-arterial hepatic fotemustine for high-risk uveal melanoma patients

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

Artificial neural networks estimating survival probability after treatment of choroidal melanoma

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

Treating some small melanocytic choroidal lesions without waiting for growth

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

Factors predictive of growth and treatment of small choroidal melanoma: COMS Report No. 5. The Collaborative Ocular Melanoma Study Group

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

Detection of uveal melanoma by optometrists in the United Kingdom

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

Choroidal melanoma endoresection, dandelions and allegory-based medicine.

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.235

7 January 2021

Identifiers

DOI

10.1038/EYE.2009.235

1 reference

Dimensions Publication ID

1 November 2017

1029740672

0 references

1 reference